This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

This Week's Key Earnings Reports

Pfizer (PFE) ($25.43): Releases their earnings report pre-market on Tuesday. The stock has a buy rating according to ValuEngine with a favorable P/E. The stock is above its 200-day simple moving average (SMA) at $22.91. Pfizer set a multi-year high at $26.09 on Oct. 18. The weekly chart is overbought with the five-week modified moving average (MMA) at 24.91 and the 200-week SMA at $18.54. Investors and traders should sell strength to my quarterly pivot at $25.74 and then employ a "buy-and-trade" strategy between the value level and risky level.

MasterCard (MA) ($452.98): Releases its earnings report pre-market on Wednesday. The stock has a buy rating according to ValuEngine with an elevated P/E and is above its 200-day SMA at $424.28. The stock set a multi-year high at $486.08 on Oct. 17. The weekly chart profile is negative with the 200-week SMA at $278.04. Investors and traders should employ a "buy-and-trade" strategy between the value level and risky level.

Stocks Reporting Pre-market Thursday

Barrick Gold (ABX) ($39.18): Has a buy rating according to ValuEngine with a favorable P/E. The stock is below its 200-day SMA at $40.69. The stock set its 2012 high at $50.39 on Feb. 2 and its 2012 low at $31.00 on July 26. The weekly chart profile is negative with the 200-week SMA at $42.42. Investors and traders should employ a "buy-and-trade" strategy between the value level and risky level.

Teva Pharmaceuticals (TEVA) ($40.39): Has a buy rating according to ValuEngine with a favorable P/E and is below its 200-day SMA at $41.94. The stock set its 2012 high at $46.38 on May 1 and its 2012 low at $37.40 on June 20. The weekly chart is neutral with the stock below its 200-week SMA at $47.96. Investors and traders should employ a "buy-and-trade" strategy between the value level and risky level.

Exxon Mobile (XOM) ($90.62): Has a buy rating according to ValuEngine with a reasonable P/E and is above its 200-day SMA at $86.24. The stock set a multi-year high at $93.67 on Oct. 19. The weekly chart is overbought and shifts to negative with a weekly close below the five-week MMA at $90.70. The 200-week SMA is at $74.98. Investors and traders should employ a "buy-and-trade" strategy between the value level and risky level.

2 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,943.81 +28.74 0.17%
S&P 500 1,967.57 +2.89 0.15%
NASDAQ 4,415.49 +19.2860 0.44%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs